Last updated on September 2015

Aqua Therapy in Deep Venous Thrombosis and Insufficiency


Brief description of study

The purpose of this study is to test whether addition of aquatic exercise to conventional treatment helps reduce the adverse outcomes of deep vein thrombosis and reduce the severity of chronic venous insufficiency.

Detailed Study Description

Post-thrombotic syndrome (PTS) develops in approximately 25-60% of patients with acute lower extremity deep venous thrombosis (DVT) depending on severity, chronicity, anatomic level of involvement and efficacy of anticoagulation.The frequency increases with occlusive iliac venous thrombosis. PTS results in significant morbidity and a staggering toll on health careresources . PTS is reduced by early percutaneous endovenous intervention and administration of new oral anticoagulants. There are conflicting results on the efficacy of compression stockings . In general, exercise has been useful in activation of the muscle pump and improvement of symptoms. There are no data about exercise in a swimming pool. Both walking or swimming reduce the effect of joint contact and therefore pain which is particularly useful in patients with arthritis or heavyweight. Furthermore with less effect of gravity, absorption of edema would be faster. There are no data on the role of water activity in the reduction of measures of venous insufficiency.The purpose of this study is to assess whether the encouragement of patients to perform aqua activity above and beyond the recommended treatment would positively impact chronic venous insufficiency.

Clinical Study Identifier: NCT02553720

Contact Investigators or Research Sites near you

Start Over

Mohsen SHARIFI

Arizona cardiovascular consultants
Mesa, AZ United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.